Urology

Prof. Dr. Deniz Bolat

Doctor and researcher İzmir Şehir Hastanesi İzmir
Urinary Bladder NeoplasmsProstatic NeoplasmsPremature EjaculationErectile Dysfunction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Urinary Bladder Neoplasms 13 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Prostatic Neoplasms 4 publications
  • Premature Ejaculation 2 publications
  • Erectile Dysfunction 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyUrologysaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workUrinary Bladder NeoplasmsExtracted from 13 publications · Model version —From source
  • Publications96 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0001-7338-8737ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046503/doktorlarimiz.html#deniz-bolatsaglik.gov.tr

Scientific work

Publications on Urinary Bladder Neoplasms

96 publications
  1. In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?

    The Prostate, 2026

    DOI 10.1002/pros.70151 PMID 41773708 Open-access full textSource: ORCID

  2. A Deep Learning-Based Decision Support System for Cholelithiasis in MRI Data

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051891 PMID 41827308 Open-access full textSource: ORCID

  3. Beyond Clinical Staging: The Combined Value of mpMRI Lesion Size and Cancer-positive Biopsy Core Rate in Predicting ≥ pT3 Disease

    Bulletin of Urooncology, 2026

    DOI 10.4274/uob.galenos.2026.2026.7.9 Open-access full textSource: OpenAlex

  4. What do the current popular artificial intelligence chatbots offer us regarding patient information? Comparison of responses from the ten most popular chatbots about bladder cancer

    Journal of Cancer Survivorship, 2026

    DOI 10.1007/s11764-025-01921-2 PMID 41258614 4 citations (Europe PMC) Source: ORCID

  5. Association of the Preoperative Albumin-to-Globulin Ratio with Pathological Stage and Tumor Grade in Primary Bladder Tumor

    Endouroloji Bulteni, 2026

    DOI 10.54233/endourolbull-1954790 Open-access full textSource: ORCID

  6. Outcomes and Predictive Factors for Gynecologic Organ Involvement in Radical Cystectomy for Female Bladder Cancer Patients: A Multicenter Retrospective Cohort Study

    Medicina, 2026

    DOI 10.3390/medicina62081609 PMID 42654506 Open-access full textSource: ORCID

  7. Comparison of Oncologic and Functional Outcomes of Orifice Resection via Monopolar and Bipolar System in Bladder Tumors with Orifice Involvement

    Urologia Internationalis, 2026

    DOI 10.1159/000550478 PMID 41528962 Source: OpenAlex

  8. Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association

    Clinical Genitourinary Cancer, 2025

    DOI 10.1016/j.clgc.2025.102432 PMID 41076397 Source: OpenAlex

  9. Effect of Bacillus Calmette-Guérin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor

    Urology, 2025

    DOI 10.1016/j.urology.2024.12.003 PMID 39672342 Source: ORCID

  10. The effect of neoadjuvant chemotherapy on survival outcomes in patients with variant histologies who underwent radical cystectomy with precystectomy diagnostic accuracy: A multicenter study of the Turkish Urooncology Association

    International Journal of Urology, 2025

    DOI 10.1111/iju.15683 PMID 39835617 4 citations (OpenAlex) Source: OpenAlex

View all 96 publications